1. Home
  2. CQP vs NTRA Comparison

CQP vs NTRA Comparison

Compare CQP & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CQP
  • NTRA
  • Stock Information
  • Founded
  • CQP 2003
  • NTRA 2003
  • Country
  • CQP United States
  • NTRA United States
  • Employees
  • CQP N/A
  • NTRA N/A
  • Industry
  • CQP Oil/Gas Transmission
  • NTRA Medical Specialities
  • Sector
  • CQP Utilities
  • NTRA Health Care
  • Exchange
  • CQP Nasdaq
  • NTRA Nasdaq
  • Market Cap
  • CQP 24.8B
  • NTRA 27.0B
  • IPO Year
  • CQP 2007
  • NTRA 2015
  • Fundamental
  • Price
  • CQP $52.34
  • NTRA $214.05
  • Analyst Decision
  • CQP Strong Sell
  • NTRA Strong Buy
  • Analyst Count
  • CQP 5
  • NTRA 16
  • Target Price
  • CQP $54.60
  • NTRA $224.25
  • AVG Volume (30 Days)
  • CQP 186.6K
  • NTRA 1.4M
  • Earning Date
  • CQP 10-30-2025
  • NTRA 11-06-2025
  • Dividend Yield
  • CQP 6.23%
  • NTRA N/A
  • EPS Growth
  • CQP N/A
  • NTRA N/A
  • EPS
  • CQP 3.84
  • NTRA N/A
  • Revenue
  • CQP $10,308,000,000.00
  • NTRA $2,116,676,000.00
  • Revenue This Year
  • CQP $25.74
  • NTRA $25.70
  • Revenue Next Year
  • CQP $5.91
  • NTRA $15.42
  • P/E Ratio
  • CQP $13.71
  • NTRA N/A
  • Revenue Growth
  • CQP 15.43
  • NTRA 38.17
  • 52 Week Low
  • CQP $49.53
  • NTRA $125.38
  • 52 Week High
  • CQP $68.42
  • NTRA $215.81
  • Technical
  • Relative Strength Index (RSI)
  • CQP 48.53
  • NTRA 70.61
  • Support Level
  • CQP $51.55
  • NTRA $195.14
  • Resistance Level
  • CQP $54.25
  • NTRA $215.81
  • Average True Range (ATR)
  • CQP 1.46
  • NTRA 8.08
  • MACD
  • CQP 0.08
  • NTRA 0.37
  • Stochastic Oscillator
  • CQP 55.68
  • NTRA 92.29

About CQP Cheniere Energy Partners LP Common Units

Cheniere Energy Partners is a liquified natural gas producer operating one facility in Sabine Pass, Louisiana. It generates most of its revenue through long-term contracts with customers on a fixed- and variable-fee payout structure. It also generates revenue by selling uncontracted LNG to customers on a short or one-time basis. The profit generated through those activities is split with parent and operator Cheniere Energy.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: